IVF May Not Increase Breast Cancer Risk

A recent study found no association between in vitro fertilization (IVF) and an increased risk of breast cancer.

Since IVF increases estradiol and progesterone temporarily, it was thought that IVF could potentially increase the risk of breast cancer, but there have been no long-term studies to examine this relationship. Researchers in the current study published by JAMA, conducted a long-term study with a median follow-up for 21 years.

The examined the risk of breast cancer in 19,158 women who underwent IVF between 1983 and 1995. They also included 5950 women who underwent other fertility treatments between 1980 and 1995.

Researchers found 839 cases of invasive breast cancer and 109 cases of in situ breast cancer. They discovered that the incidences of cancer were 3% for women who underwent IVF, and 2.9% for women who underwent other treatments.

They did not find that the risk was effected by the type of fertility drugs or diagnosis; however, women with 7 or more IVF cycles had a decreased risk compared with women who only had 1 or 2 cycles.

A decreased risk was also seen among women who had a poor response to the initial IVF treatment.

"These findings are consistent with the absence of a significant increase in the long-term risk of breast cancer among women treated with these IVF regimens," the authors concluded.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Study explores the efficiency and accuracy of aspirin in colorectal cancer prevention.
Translational study of breast cancer therapy sought to ‘take research from bench to bedside.’
Top news of the day across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$